152 related articles for article (PubMed ID: 1723168)
1. Serological analysis of tumor antigens in malignant glioma patients.
Yoshida S; Tanaka R; Ono K
Neurol Med Chir (Tokyo); 1991 Sep; 31(9):559-62. PubMed ID: 1723168
[TBL] [Abstract][Full Text] [Related]
2. Human glioma-specific antigens detected by monoclonal antibodies.
Kondo S; Miyatake S; Iwasaki K; Oda Y; Kikuchi H; Zu Y; Shamoto M; Namba Y
Neurosurgery; 1992 Apr; 30(4):506-11. PubMed ID: 1584348
[TBL] [Abstract][Full Text] [Related]
3. Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence.
Solheid C; Lauro G; Palladini G
J Neurol Sci; 1976 Nov; 30(1):55-64. PubMed ID: 789826
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the humoral response of meningioma patients to possible common tumour-associated antigens.
Mottet S; Martin-Achard A; de Tribolet N; Diserens AC
Acta Neurochir (Wien); 1980; 52(1-2):19-25. PubMed ID: 7376941
[TBL] [Abstract][Full Text] [Related]
5. Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls.
Fischer U; Struss AK; Hemmer D; Pallasch CP; Steudel WI; Meese E
Clin Exp Immunol; 2001 Nov; 126(2):206-13. PubMed ID: 11703362
[TBL] [Abstract][Full Text] [Related]
6. Autologous serologic responses in glioma patients. Correlation with tumor grade and survival.
Kornblith PL; Coakham HB; Pollock LA; Wood WC; Green SB; Smith BH
Cancer; 1983 Dec; 52(12):2230-5. PubMed ID: 6640493
[TBL] [Abstract][Full Text] [Related]
7. Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays.
Coakham HB; Kornblith PL; Quindlen EA; Pollock LA; Wood WC; Hartnett LC
J Natl Cancer Inst; 1980 Feb; 64(2):223-33. PubMed ID: 6153405
[TBL] [Abstract][Full Text] [Related]
8. Absence of p53 autoantibodies in sera from glioma patients.
Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
[TBL] [Abstract][Full Text] [Related]
9. [Autoimmune response in the serum of patients with cerebral gliomas].
González C; Fumanal FJ; Roda JE
Rev Clin Esp; 1984 Apr; 173(1):45-7. PubMed ID: 6739896
[No Abstract] [Full Text] [Related]
10. MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies.
Comtesse N; Niedermayer I; Glass B; Heckel D; Maldener E; Nastainczyk W; Feiden W; Meese E
Oncogene; 2002 Jan; 21(2):239-47. PubMed ID: 11803467
[TBL] [Abstract][Full Text] [Related]
11. Natural antibodies to cell-surface antigens of human astrocytoma.
Pfreundschuh M; Röhrich M; Piotrowski W; Berlit P; Penzholz H
Int J Cancer; 1982 May; 29(5):517-21. PubMed ID: 7095897
[TBL] [Abstract][Full Text] [Related]
12. Common antigen in meningioma-derived cell cultures.
Catalano LW; Harter DH; Hsu KC
Science; 1972 Jan; 175(4018):180-2. PubMed ID: 4332758
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas.
Schmits R; Cochlovius B; Treitz G; Regitz E; Ketter R; Preuss KD; Romeike BF; Pfreundschuh M
Int J Cancer; 2002 Mar; 98(1):73-7. PubMed ID: 11857388
[TBL] [Abstract][Full Text] [Related]
14. Specific cellular immune responses in patients with malignant gliomas.
Sheikh KM; Apuzzo ML; Weiss MH
Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
[TBL] [Abstract][Full Text] [Related]
15. [Immunofluorescence microscopy of a malignant glioma with regard to the occurrence and significance of glioma specific antibodies].
Hackenberg P; Koschnike P
Psychiatr Neurol Med Psychol (Leipz); 1980 Apr; 32(4):206-13. PubMed ID: 7413856
[TBL] [Abstract][Full Text] [Related]
16. Human intracranial tumors: effect of autologous serum addition on leucocyte migration inhibition.
Böker DK
Acta Neurochir (Wien); 1982; 65(3-4):227-37. PubMed ID: 7180599
[TBL] [Abstract][Full Text] [Related]
17. Serological analysis of cell surface antigens of malignant human brain tumors.
Pfreundschuh M; Shiku H; Takahashi T; Ueda R; Ransohoff J; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5122-6. PubMed ID: 283420
[TBL] [Abstract][Full Text] [Related]
18. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
19. Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.
Comtesse N; Zippel A; Walle S; Monz D; Backes C; Fischer U; Mayer J; Ludwig N; Hildebrandt A; Keller A; Steudel WI; Lenhof HP; Meese E
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9601-6. PubMed ID: 15983380
[TBL] [Abstract][Full Text] [Related]
20. Serum immunoglobulins in brain tumours.
Manjula S; Aroor AR; Raja A; Rao SN; Rao A
Acta Neurochir (Wien); 1992; 115(3-4):103-5. PubMed ID: 1605076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
